SMR

NuScale holds the only U.S. Nuclear Regulatory Commission (NRC) design certification among small modular reactor (SMR) developers. This certification is a critical regulatory milestone that validates the safety and design of its reactor, potentially shortening the path to commercial deployment. It differentiates NuScale from competitors like Oklo and X-Energy, which have not yet achieved this status. However, certification alone does not guarantee revenue; the company still needs to secure firm customer commitments and power purchase agreements. The certification is a long-term asset that could become more valuable if the SMR market matures, but it currently does not offset the immediate financial and dilution risks.

A $750 million share sale would likely be executed through an at-the-market offering or a secondary issuance, increasing the total share count. This dilution reduces the ownership stake of existing shareholders and can pressure the stock price, as each share represents a smaller claim on future earnings and assets. For NuScale, which already has a market cap around $4 billion, a $750 million raise represents roughly 19% of its current value, making the dilution impact substantial. The proceeds could fund operations and development, but given the company's negligible revenue, the market may view the sale as a sign of financial distress rather than growth investment.

On September 10, NuScale fell 5% in sympathy with a sector-wide selloff triggered by Piper Sandler's negative coverage of competitor X-Energy. This illustrates NuScale's vulnerability to peer sentiment, as investors often treat SMR stocks as a group. Even though NuScale has a unique regulatory advantage, it cannot decouple from the broader perception of the sector. The drop was purely sentiment-driven, not based on any change in NuScale's fundamentals. This event highlights the importance of monitoring sector-wide news and analyst actions, as they can move the stock independently of company-specific developments. It also suggests that a positive catalyst specific to NuScale, such as a TVA milestone, would be needed to break this pattern.

In June, a BNP Paribas fund that outperformed 97% of peers rotated into SMR stocks, including NuScale, citing depressed valuations and the long-term energy transition. This is a notable endorsement from a high-conviction institutional investor, suggesting that some smart money sees value after the stock's sharp decline. However, the fund's thesis is multi-year and does not address near-term risks like the $750 million share sale or the lack of revenue. The rotation may provide a floor for the stock in the long run, but it has not been enough to reverse the bearish momentum. Investors should view this as a signal of potential long-term upside, but it does not negate the immediate fundamental and technical pressures.